Proton Therapy Systems Market Size, Share, and Growth Forecast 2026-2033

The global proton therapy systems market size is likely to be valued at US$1.7 billion in 2026 and projected to reach US$3.2 billion by 2033, growing at a CAGR of 9.5% during the forecast period between 2026 and 2033, driven by rising global cancer incidence and growing preference for radiation techniques that spare healthy tissue, which continue to support demand for proton therapy systems. Compact, single-room platforms are lowering the capital and space barriers that once confined proton therapy to a handful of large academic centers, widening access across community and mid-sized hospital networks.

Driver - Rising Cancer Incidence and Demand for Precision Radiation Techniques

Rising global cancer incidence is a core driver of the proton therapy systems market. The World Health Organization projects continued growth in global cancer cases over the coming decade, pushing hospitals and cancer centers to expand precision radiation oncology capacity. Proton therapy delivers radiation directly to tumor tissue and stops, sparing surrounding healthy organs, an advantage that is especially valuable for pediatric cancers and tumors located near the spine, brain, or heart.

Growing clinical evidence supporting reduced long-term side effects is encouraging oncologists to refer more patients to proton treatment, particularly for complex or hard-to-reach tumors. Expanding pediatric oncology programs at leading cancer centers are also reinforcing demand, since children are especially sensitive to radiation exposure in developing tissue. Rising government and private investment in cancer care infrastructure across both developed and emerging markets is further accelerating procurement of new proton therapy installations.

Restraint - High Capital Costs and Long Installation Timelines

Proton therapy systems require substantial upfront capital investment, spanning cyclotron or synchrotron hardware, gantry infrastructure, and facility construction. Traditional multi-room installations can take several years to plan, permit, and build, delaying the return on investment for hospitals and slowing market expansion in cost-sensitive regions.

Ongoing maintenance, specialized staffing, and software upgrade costs add further budget pressure for healthcare providers considering proton therapy adoption. Reimbursement uncertainty in several public healthcare systems can also delay large-scale investment decisions, particularly outside markets with established proton-specific coverage policies.

Opportunity - Compact, Single-Room Systems Expanding Market Access

Growing availability of compact, single-room proton therapy platforms is opening new opportunities across community and mid-sized hospitals that previously could not justify multi-room investment. Newer systems designed to fit inside existing radiation therapy vaults are letting cancer centers add proton capability without dedicated bunker construction, shortening installation timelines and lowering total project cost.

Expanding proton therapy adoption across Asia Pacific and the Middle East, supported by rising government healthcare investment, is expected to support long-term demand for both equipment and long-term service contracts. Growing focus on pediatric and rare-cancer treatment centers is also encouraging manufacturers to develop lower-cost, space-efficient systems suited to a broader range of hospital settings.

Product Type Insights

Equipment is estimated to lead the product type segment, commanding close to 78% of global market revenue in 2026, fueled by proton therapy systems that require high-value, specialized hardware for each installation. The equipment segment includes major components such as cyclotrons, synchrocyclotrons, gantries, beam-delivery systems, treatment rooms, and related control equipment. These systems involve substantial upfront investment, which makes equipment the largest contributor to market revenue.

Services are likely to be the fastest-growing segment, as the number of installed proton therapy systems increases worldwide. These highly specialized systems require regular maintenance, calibration, software updates, technical support, replacement of components, and system upgrades to maintain accurate and reliable treatment operations. As more hospitals install proton therapy equipment, the need for ongoing support continues throughout the system's operating life.

System Type Insights

Multi-room systems are anticipated to lead the system type segment, holding around 58% share of global revenue in 2026, owing to the fact that they are already widely installed in large academic hospitals, comprehensive cancer centers, and major referral facilities. These institutions typically treat a high number of cancer patients and need to provide proton therapy to multiple patients at the same time.

 Single-room systems are likely to be the fastest-growing system type, as their smaller and more compact configuration can reduce the space, infrastructure, and investment requirements associated with proton therapy installation. This makes them more suitable for community hospitals and mid-sized cancer centers that may not have enough patient volume or financial capacity to justify a multi-room facility.

Technology Insights

Cyclotron-based systems are expected to dominate, accounting for nearly 52% of global demand in 2026 because they provide a practical balance of reliable beam delivery, compact equipment size, and operational flexibility. Unlike technologies that produce pulsed or intermittent beams, cyclotrons can provide a continuous particle beam, which supports consistent proton delivery during treatment.

Synchrocyclotron-based systems are likely to be the fastest-growing, driven by they are designed to reduce the space and infrastructure requirements of proton therapy facilities. Their smaller size and lower power requirements can make installation more manageable, particularly for single-room proton therapy centers.

North America Proton Therapy Systems Market Trends

North America is forecast to dominate, capturing around 45% of the proton therapy systems market revenue in 2026. Dense concentration of established proton centers, favorable reimbursement pathways for radiation oncology, and strong presence of leading system manufacturers support regional growth. Growing adoption of compact single-room systems designed for existing radiation therapy vaults is adding further momentum by lowering the barrier to entry for community hospital networks.

U.S. Proton Therapy Systems Market Trends

The U.S. is projected to account for close to 85% of North American market share in 2026. This position is supported by the country's large cancer patient population, established proton therapy infrastructure, and strong presence of specialized cancer centers. Demand is also supported by the increasing use of proton therapy for pediatric cancers and complex tumors, where minimizing radiation exposure to surrounding healthy tissue is particularly important.

Canada Proton Therapy Systems Market Trends

Canada is expected to hold close to 15% of the North American market share in 2026. Demand is particularly supported by referrals for pediatric cancers and complex tumors, where proton therapy can be considered when reducing radiation exposure to healthy tissues is clinically important. As healthcare providers seek to expand access to advanced radiation treatments, investment in proton therapy infrastructure is expected to increase gradually.

Europe Proton Therapy Systems Market Trends

Europe is estimated to account for approximately 28% of the global market revenue in 2026, supported by its well-developed healthcare infrastructure and continued investment in advanced cancer treatment. Many European countries have publicly funded healthcare systems, which makes it possible for governments and healthcare institutions to invest in high-cost technologies such as proton therapy.

Germany Proton Therapy Systems Market Trends

Germany is projected to lead within Europe, holding close to 26% of the regional market share in 2026. The country's position is supported by its large network of university hospitals, cancer centers, and medical research institutions. These facilities have the clinical expertise and infrastructure needed to adopt sophisticated radiation technologies such as proton therapy.

U.K. Proton Therapy Systems Market Trends

The U.K. is expected to hold around 19% of the European market share in 2026. A major factor supporting the market is investment by the National Health Service (NHS) in dedicated proton therapy infrastructure. The development of specialized treatment centers has increased domestic access to proton therapy and reduced the need for eligible patients to travel overseas for treatment.

Asia Pacific Proton Therapy Systems Market Trends

Asia Pacific is likely to be the fastest-growing region, expanding at a CAGR of approximately 11.4% from 2026 to 2033. This growth is driven by the rapid expansion of cancer-care infrastructure and specialized hospitals across countries such as China, India, Japan, South Korea, and Southeast Asia. As cancer diagnosis and treatment capacity expand, hospitals are increasingly adding advanced radiation technologies to offer more specialized treatment options. The limited availability of proton therapy centers in many Asian countries compared with developed markets.

China Proton Therapy Systems Market Trends

China is projected to dominate Asia Pacific, accounting for close to 34% of the regional market in 2026. China's large population and expanding healthcare system create a substantial market for advanced cancer-treatment technologies. The country has been expanding large hospitals, specialized cancer centers, and high-end medical infrastructure, creating more opportunities for proton therapy installations.

India Proton Therapy Systems Market Trends

India is expected to be the fastest-growing country within Asia Pacific, supported by rising cancer incidence and growing private hospital investment in advanced oncology infrastructure. India attracts international patients seeking relatively accessible and specialized medical treatment, including cancer care. The development of advanced radiation facilities can strengthen the country's position as a destination for patients seeking precision cancer treatment.

The global proton therapy systems market is moderately consolidated, led by established particle-accelerator manufacturers with broad multi-room and single-room platform portfolios. IBA (Ion Beam Applications SA), Varian Medical Systems, and Hitachi, Ltd. represent leading market participants, competing on beam-delivery precision, installation footprint, and global service infrastructure across academic and community cancer centers. Mevion Medical Systems continues to strengthen its position in compact, single-room systems designed for existing radiation therapy vaults.

Sumitomo Heavy Industries, Ltd., Mitsubishi Electric Corporation, ProTom International, Advanced Oncotherapy plc, ProNova Solutions, LLC, and Optivus Proton Therapy, Inc. maintain regional and specialized positions, expanding manufacturing capacity and technology partnerships to serve growing hospital investment across North America, Europe, and Asia Pacific. Competitive dynamics center on shortening installation timelines, expanding compact system portfolios, and broadening service networks to reduce total cost of ownership for hospitals.

Key Industry Developments:

• In April 2026, Stanford Medicine launched the world’s first upright, compact proton therapy delivery system at the Stanford Medicine Cancer Center in Palo Alto, California. The system allowed patients to remain upright during treatment and was compact enough to fit inside a standard linear accelerator vault.
• In August 2023, Hitachi, Ltd. and Hitachi Asia Ltd. delivered a proton therapy system to the National Cancer Centre Singapore (NCCS), which completed its first patient treatment. The installation marked Hitachi’s first proton therapy system to begin patient treatment in Southeast Asia. The system featured five treatment rooms, including four rooms with rotating gantries and one fixed-beam room.